ImNO would like to thank the current and past industry, commercialization and research networks for their support.
This year's supporting organizations are:
Program Co-Director: Dr. Aaron Fenster and and Martin Yaffe
Sponsor: Ontario Institute of Cancer Research (OICR)
The OICR Imaging Program (OICR IP) accelerates the translation of research into the development of new imaging innovations for earlier cancer detection, diagnosis and treatment through four major projects; probe development and commercialization, medical imaging instrumentation and software, pathology validation, and imaging for clinical trials.
OICR IP facilitates improved screening and treatment options for cancer patients by streamlining advances in medical imaging through the complex pipeline from discovery through clinical translation and ultimately to clinical use.
Machine Learning for Medical Imaging Working Group: Aaron Fenster, Anne Martel, Julia Publicover, Amber L. Simpson, Aaron Ward, Martin Yaffe
The Consortium was launched to accelerate research and development of machine learning solutions for unmet needs in medical imaging through collaborations between academic and clinical researchers, and with Canadian industry.
Ontario Network of Excellence for Translation of Hyperpolarized MRI Technologies Consortium
Lead Researcher: Dr. Charles Cunningham
Sponsor: Ontario Research Fund (ORF)
Ontario is home to five major research groups developing new forms of MRI based on Hyperpolarized (HP) contrast agents, with the aim of transforming patient care for conditions such as cancer, heart failure and lung disease. Just as an injection of dye prior to an x-ray exam can reveal important new information, the introduction of HP contrast agents, which are magnetized to be directly detectable in an MRI scan, can open up many new applications of MRI. Several HP agents have been developed in the past 20 years for MR imaging, and Ontario is uniquely positioned to take a leadership role in the development of the next generation of agents and technologies, with expertise and activity in all of the related technology development areas. The overall objective of this program is to integrate and develop this substantial expertise, creating an Ontario Network of Excellence, bringing these technologies forward to commercialization and, ultimately, application in the health system. Each of the related technologies is being developed in partnership with MRI hardware vendors and pharmaceutical companies for application in targeted disease areas.
There are five major centres of activity in HP-MRI in Ontario led by: Mitchell Albert in Thunder Bay, Andrea Kassner and Giles Santyr at the Hospital for Sick Children in Toronto, Charles Cunningham at Sunnybrook Health Sciences Centre in Toronto, Charles McKenzie, Grace Parraga and Timothy Scholl at the Robarts Research Institute in London, and Michael Noseworthy in Hamilton
Scintica's mission is to link scientists with the right precision tools to further research by providing high-value instrumentation and research solutions to scientists and the preclinical research community. We are a leading supplier of medical research solutions and provide elite applications, technical support, and a platform for today's scientists to share their scientific findings. We carry a diverse portfolio of products, ranging from imaging systems (PET, CT, MRI, optical, DEXA, intravital microscopy, photoacoustic and high-frequency ultrasound systems), lab equipment, instruments, workstations, incubators, tissue culture analysis, and much more.
NDI is the world's leading innovator of optical and electromagnetic navigation technology. For 40+ years, we’ve helped medical device OEMs bring new surgical navigation applications—and clinical breakthroughs—to market.
The following organizations have supported ImNO in the past.
- 7D Surgical
- Fujifilm VisualSonic, Inc
- GE Healthcare
- Scintica Instrumentation Inc.
- Shelley Medical Imaging Technologies
Research and commercialization organizations
- Biomedical Computing Laboratory, Queen’s University
- Biomedical Imaging Research Centre, Western University
- Building a Better Brain: An Ontario Neuroimaging Consortium
- Canadian Atherosclerosis Imaging Network
- Cancer Care Ontario Cancer Imaging Network of Ontario (CCO-CINO)
- Cardiac Arrhythmia Network of Canada (CANet)
- Centre for Imaging Technology Commercialization (CIMTEC)
- Development & Translation of MRI Technology for Neuro-Interventional Applications
- Development of Novel Therapies for Bone and Joint Diseases
- Effective Systems for Procedure Specific Healthcare Simulation (Simulation)
- Focused Ultrasound Devices for Noninvasive Surgery and Drug Delivery (FUSD)
- Heart Failure: Prevention through Early Detection Using New Imaging Methods
- Hyperpolarized 13C MRI of Placental Metabolic Abnormalities Resulting from the Western Diet (HIH-NICHD)
- Image-Guided Device Interventions for Cardiovascular Disease
- Machine Learning in Medical Imaging Consortium (MaLMIC)
- Medical Imaging Trial Network of Canada (MITNEC)
- Next-Generation Innovations in Ultrasonics (N-Genius)
- Ontario Consortium for Adaptive Interventions in Radiation Oncology (OCAIRO)
- Ontario Consortium for Small Animal Imaging (OCSAI)
- Ontario Consortium in Imaging for Cardiovascular Therapeutics (OCICT)
- Ontario Institute for Cancer Research Imaging Pipeline Platform (OICR-IPP)
- Ontario Institute for Cancer Research Imaging Program (OICR-IP)
- Ontario Institute for Cancer Research Imaging Translation Platform (OICR-ITP)
- Ontario Institute for Cancer Research One Millimetre Cancer Challenge Program (OICR-1mmCC)
- Ontario Institute for Cancer Research Smarter Imaging Program (OICR-SIP)
- Ontario Network for Advanced Medical Imaging Detectors (ONAMID)
- Ontario Network of Excellence for Translation of Hyperpolarized MRI Technologies
- Ontario Preclinical Imaging Consortium (OPIC)
- Western University’s Bone and Joint Institute